Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
299
-
Total 13F shares, excl. options
-
71.1M
-
Shares change
-
-364K
-
Total reported value, excl. options
-
$1.06B
-
Value change
-
-$156K
-
Put/Call ratio
-
0.02
-
Number of buys
-
161
-
Number of sells
-
-124
-
Price
-
$14.87
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2025
342 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2025.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 299 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.1M shares
.
Largest 10 shareholders include Capital Research Global Investors (13.2M shares), MORGAN STANLEY (5.7M shares), GOLDMAN SACHS GROUP INC (5.32M shares), FMR LLC (3.87M shares), BRANDES INVESTMENT PARTNERS, LP (3.5M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.43M shares), RENAISSANCE TECHNOLOGIES LLC (3.16M shares), FIRST TRUST ADVISORS LP (2.76M shares), BlackRock, Inc. (2.63M shares), and VAN ECK ASSOCIATES CORP (2.17M shares).
This table shows the top 299 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.